| Phase 111 trials |
|
Phase 1
|
NCT01204476 |
Oct 2010 → Jul 2014 |
PPoma, cutaneous neuroendocrine carcinoma, gastrin-producing neuroendocrine tumor, glucagonoma +5 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01182883 |
Jul 2010 → Apr 2012 |
brainstem neoplasm, glioma, pineal body neoplasm |
National Cancer Institute (NCI) |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT01061749 |
Nov 2009 → Apr 2013 |
neoplasm |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01007032 |
Nov 2009 → Dec 2012 |
neoplasm |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT01008566 |
Aug 2009 → May 2016 |
adult hepatocellular carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00880282 |
Apr 2009 → Oct 2012 |
childhood malignant neoplasm |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00720174 |
Jun 2008 → Jan 2013 |
adult epithelioid sarcoma, adult extraskeletal osteosarcoma, adult fibrosarcoma, adult liposarcoma +17 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00678769 |
May 2008 → Jun 2013 |
cancer |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00609141 |
Jan 2008 → Sep 2009 |
Ewing sarcoma/peripheral primitive neuroectodermal tumor, childhood malignant neoplasm |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00785941 |
Apr 2006 → Oct 2007 |
cancer |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 1
|
NCT00785538 |
Oct 2005 → Jan 2011 |
cancer |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
| Phase 1/24 trials |
|
Phase 1/2
|
NCT01026623 |
Oct 2009 → Feb 2013 |
hormone-resistant prostate carcinoma, prostate adenocarcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT00699491 |
Oct 2008 → Sep 2013 |
male breast carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT00778167 |
Oct 2008 → May 2012 |
non-small cell lung carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 1/2
|
NCT00617708 |
Mar 2008 → Sep 2012 |
pancreas disorder |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
| Phase 228 trials |
|
Phase 2
|
NCT01614795 |
Jun 2012 → Apr 2014 |
Ewing sarcoma/peripheral primitive neuroectodermal tumor, alveolar soft part sarcoma, childhood epithelioid sarcoma, gliosarcoma +7 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00957853 |
Oct 2011 → Aug 2018 |
head and neck squamous cell carcinoma |
M.D. Anderson Cancer Center |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01413191 |
Aug 2011 → Mar 2013 |
iris melanoma, medium/large size posterior uveal melanoma, small size posterior uveal melanoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01263782 |
May 2011 → Aug 2017 |
lung cancer |
M.D. Anderson Cancer Center |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01232452 |
Apr 2011 → Jan 2013 |
non-small cell lung carcinoma |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01120236 |
Dec 2010 → Jun 2015 |
prostate adenocarcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01142388 |
Sep 2010 → Jul 2014 overdue |
esophageal adenocarcinoma, esophageal squamous cell carcinoma, gastroesophageal junction adenocarcinoma |
National Cancer Institute (NCI) |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT01160458 |
Jun 2010 → Aug 2016 |
malignant peritoneal mesothelioma, malignant pleural mesothelioma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00955305 |
Mar 2010 → Jan 2016 |
lung adenocarcinoma, lung large cell carcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT01055314 |
Jan 2010 → Jun 2016 |
alveolar rhabdomyosarcoma, embryonal rhabdomyosarcoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT01016015 |
Nov 2009 → Jul 2014 |
osteosarcoma, soft tissue sarcoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00986674 |
Sep 2009 → Aug 2013 |
non-small cell lung carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00965250 |
Aug 2009 → Mar 2012 |
thymic carcinoma, thymic neuroendocrine tumor, thymoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00887159 |
Jul 2009 → Nov 2016 |
small cell lung carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00845039 |
May 2009 → Feb 2011 |
colon carcinoma, rectal cancer |
Eli Lilly and Company |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT00870870 |
Mar 2009 → Apr 2012 |
non-small cell lung carcinoma |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00781911 |
Feb 2009 → Jul 2011 |
carcinoma, neuroendocrine neoplasm |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00831844 |
Jan 2009 → Apr 2013 |
Ewing sarcoma/peripheral primitive neuroectodermal tumor, adrenal cortex carcinoma, childhood kidney neoplasm, hepatoblastoma +5 |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00778817 |
Dec 2008 → May 2012 |
adrenal cortex carcinoma |
National Cancer Institute (NCI) |
Terminated
|
No outcome recorded
|
|
Phase 2
|
NCT00769795 |
Oct 2008 → Aug 2011 |
prostate cancer |
University of Washington |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00728949 |
Aug 2008 → Mar 2012 |
breast cancer |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00683475 |
Aug 2008 → Sep 2011 |
prostate cancer |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00684983 |
Jul 2008 → Jan 2014 |
HER2 positive breast carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00668148 |
Jul 2008 → Oct 2010 |
Ewing sarcoma/peripheral primitive neuroectodermal tumor, leiomyosarcoma, liposarcoma, rhabdomyosarcoma +1 |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00617734 |
Mar 2008 → Feb 2012 |
head and neck cancer |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00639509 |
Mar 2008 → Feb 2011 |
adult hepatocellular carcinoma |
National Cancer Institute (NCI) |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00520481 |
Aug 2007 → Jan 2012 |
prostate adenocarcinoma |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT00503685 |
Jun 2007 → Mar 2009 |
colorectal cancer |
Eli Lilly and Company |
Completed
|
No outcome recorded
|
|